Results 261 to 265 of about 54,453 (265)
Some of the next articles are maybe not open access.
Human medicines European public assessment report (EPAR): Humira, adalimumab, Spondylitis, Ankylosing,Arthritis, Juvenile Rheumatoid,Uveitis,Colitis, Ulcerative,Psoriasis,Arthritis, Psoriatic,Crohn Disease,Arthritis, Rheumatoid, Date of authorisation: 07/09/2003, Revision: 73, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 1, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Hidradenitis Suppurativa,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Skin Diseases, Papulosquamous,Arthritis, Psoriatic, Date of authorisation: 26/07/2018, Revision: 2, Status: Authorised
Case Medical Research, 2019 openaire +1 more sourceHuman medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Hidradenitis Suppurativa,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Skin Diseases, Papulosquamous,Arthritis, Psoriatic, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised
Case Medical Research, 2019 openaire +1 more source